Obesity and hypertension.
Seravalle G, Grassi G.
Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19.
Obesity subtypes, related biomarkers & heterogeneity.
Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP, Rodal Canales FJ, Cabrera-Fuentes HA, Cruz MM, Pérez Santiago AD, Alpuche JJ, Zenteno E, Ruíz HM, Cruz RM, Jeronimo JH, Perez-Campos E.
Indian J Med Res. 2020 Jan;151(1):11-21. doi: 10.4103/ijmr.IJMR_1768_17.
Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.
Piché ME, Tchernof A, Després JP.
Circ Res. 2020 May 22;126(11):1477-1500. doi: 10.1161/CIRCRESAHA.120.316101. Epub 2020 May 21.
Humans against Obesity: Who Will Win?
Caballero B.
Adv Nutr. 2019 Jan 1;10(suppl_1):S4-S9. doi: 10.1093/advances/nmy055.
Contemporary medical, device, and surgical therapies for obesity in adults.
Perdomo CM, Cohen RV, Sumithran P, Clément K, Frühbeck G.
Lancet. 2023 Apr 1;401(10382):1116-1130. doi: 10.1016/S0140-6736(22)02403-5. Epub 2023 Feb 9.
Current Treatments for Patients with Genetic Obesity.
Faccioli N, Poitou C, Clément K, Dubern B.
J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):108-119. doi: 10.4274/jcrpe.galenos.2023.2023-3-2. Epub 2023 May 16.
The hematologic consequences of obesity.
Purdy JC, Shatzel JJ.
Eur J Haematol. 2021 Mar;106(3):306-319. doi: 10.1111/ejh.13560. Epub 2020 Dec 13.
Obesity and female infertility: potential mediators of obesity's impact.
Broughton DE, Moley KH.
Fertil Steril. 2017 Apr;107(4):840-847. doi: 10.1016/j.fertnstert.2017.01.017. Epub 2017 Mar 11.
Obesity as a disease: no lightweight matter.
Conway B, Rene A.
Obes Rev. 2004 Aug;5(3):145-51. doi: 10.1111/j.1467-789X.2004.00144.x.
Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial.
Irfan H.
Curr Probl Cardiol. 2024 Jan;49(1 Pt A):102060. doi: 10.1016/j.cpcardiol.2023.102060. Epub 2023 Aug 26.
